EHA 2022 | Approaching NK/T-cell lymphoma

Won-Seog Kim • 11 Jun 2022

EHA 2022

Lymphoma NK/T-cell Lymphoma Rare Diseases

In this video, Won Seog Kim, MD, PhD, Sungkyunkwan University School of Medicine, Seoul, South Korea, shares some insights into the treatment of NK/T-cell lymphoma. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Insights into a Phase I/II study assessing golidocitinib in PTCL

Won-Seog Kim • 11 Jun 2022

Clinical evidence supporting rituximab

Won-Seog Kim • 13 Jun 2017

HDACIs in treating r/r PTCL

Won-Seog Kim • 21 Jun 2021

Standard of care of CAR-T therapies for B-cell malignancies

Won-Seog Kim • 24 Nov 2022

Related Videos

Key challenges of using the intestinal microbiome as a biomarker

CAR T-cell therapy: the importance of LTFU

CD19 CAR T-cell therapy for lymphoma

Michael Schmitt

Axicabtagene ciloleucel in the real-world: safety and efficacy